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Non-communicable disease (NCD) poses a major threat to global health and 
the economies of both developed and developing countries. NCD risk is 
partly set during early life, when environmental influences including 
parental diet, body composition and behaviours affect development of the 
fetus and newborn, establishing responses to later challenges such as 
obesogenic lifestyle.  In both developing and developed societies adverse 
consequences of over- and under-nutrition (i.e. malnutrition) co-exist.  The 
resulting risk is transmitted to future generations, e.g. via rising prevalence 
of gestational diabetes.  Epidemiological, clinical and basic science research 
now indicates underlying mechanisms, especially epigenetic processes.  
These can serve as early markers of later risk and they are in principle 
reversible by dietary, endocrine or pharmacological intervention. Even 
though NCD is a medical issue, the complex interventions needed  will 
require wider social and educational initiatives across the lifecourse as well 
as public health campaigns.  We need to take a DOHaD perspective if we 
are to meet the global NCD challenge. 
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